These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1803616)

  • 1. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.
    Ruf W; Edgington TS
    Thromb Haemost; 1991 Nov; 66(5):529-33. PubMed ID: 1803616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
    Edgington TS; Dickinson CD; Ruf W
    Thromb Haemost; 1997 Jul; 78(1):401-5. PubMed ID: 9198187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.
    Almus FE; Rao LV; Rapaport SI
    Thromb Haemost; 1989 Dec; 62(4):1067-73. PubMed ID: 2617454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
    Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
    Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
    Del Turco S; De Caterina R
    Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tissue factor activity reduces the density of cellular network formation in an in vitro model of angiogenesis.
    James NJ; Ettelaie C; Bruckdorfer KR
    Biochem Soc Trans; 2002 Apr; 30(2):217-21. PubMed ID: 12023854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.
    Fiore MM; Neuenschwander PF; Morrissey JH
    Blood; 1992 Dec; 80(12):3127-34. PubMed ID: 1467519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
    Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of tissue factor with a gamma chain homodimer of the IgE receptor type I in cultured human monocytes.
    Masuda M; Nakamura S; Murakami T; Komiyama Y; Takahashi H
    Eur J Immunol; 1996 Oct; 26(10):2529-32. PubMed ID: 8898969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
    Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
    Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIIa-tissue factor: functional importance of protein-membrane interactions.
    Morrissey JH; Neuenschwander PF; Huang Q; McCallum CD; Su B; Johnson AE
    Thromb Haemost; 1997 Jul; 78(1):112-6. PubMed ID: 9198138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of beta2-glycoprotein I on tissue factor activity.
    Ieko M; Yasukouchi T; Sawada KI; Koike T
    Semin Thromb Hemost; 1998; 24(3):211-5. PubMed ID: 9701450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD; Shobe J; Ruf W
    J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor VIIa/tissue factor complex.
    Banner DW
    Thromb Haemost; 1997 Jul; 78(1):512-5. PubMed ID: 9198205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T; Kakkar AK; Tuddenham EG; Williamson RC; Lemoine NR
    Cancer Res; 1998 Oct; 58(19):4461-7. PubMed ID: 9766679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.